12:00 AM
 | 
Aug 10, 2015
 |  BC Week In Review  |  Company News  |  Deals

Alchemia, Panther Biotechnology deal

Panther will acquire Alchemia’s Alchemia Oncology Pty Ltd. subsidiary in a deal slated to close by late October. The subsidiary’s portfolio includes the HyACT drug delivery technology and HA-Irinotecan for cancer. This...

Read the full 146 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >